Zacks Small Cap Estimates Spectral AI Q3 Earnings

Spectral AI, Inc. (NASDAQ:MDAI) – Equities research analysts at Zacks Small Cap issued their Q3 2025 EPS estimates for Spectral AI in a research note issued to investors on Monday, May 19th. Zacks Small Cap analyst J. Vandermosten forecasts that the company will post earnings of ($0.09) per share for the quarter. The consensus estimate for Spectral AI’s current full-year earnings is ($0.48) per share.

Spectral AI (NASDAQ:MDAI) last posted its quarterly earnings results on Thursday, March 27th. The company reported ($0.06) earnings per share for the quarter, beating the consensus estimate of ($0.13) by $0.07. The firm had revenue of $7.60 million during the quarter, compared to analysts’ expectations of $6.83 million.

Separately, HC Wainwright reissued a “buy” rating and issued a $3.50 price target on shares of Spectral AI in a research note on Wednesday, April 2nd.

Spectral AI Price Performance

Spectral AI stock opened at $1.38 on Wednesday. The firm has a 50 day simple moving average of $1.31 and a 200-day simple moving average of $1.68. Spectral AI has a 1-year low of $0.82 and a 1-year high of $3.25. The stock has a market cap of $34.94 million, a price-to-earnings ratio of -2.12 and a beta of 0.59.

Institutional Trading of Spectral AI

Several hedge funds have recently made changes to their positions in MDAI. Virtu Financial LLC purchased a new stake in shares of Spectral AI in the 4th quarter valued at approximately $38,000. Northern Trust Corp purchased a new position in shares of Spectral AI during the 4th quarter worth approximately $44,000. Millington Financial Advisors LLC purchased a new position in shares of Spectral AI during the 4th quarter worth approximately $85,000. Jane Street Group LLC purchased a new position in shares of Spectral AI during the 4th quarter worth approximately $92,000. Finally, Renaissance Technologies LLC purchased a new position in shares of Spectral AI during the 4th quarter worth approximately $272,000. Hedge funds and other institutional investors own 67.08% of the company’s stock.

Spectral AI Company Profile

Spectral AI, Inc, an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers.